Lido Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$375K Sell
13,574
-140,814
-91% -$3.89M ﹤0.01% 1108
2025
Q1
$4.38M Buy
154,388
+19,864
+15% +$563K 0.02% 353
2024
Q4
$5.59M Buy
134,524
+58,311
+77% +$2.42M 0.03% 290
2024
Q3
$5.09M Buy
76,213
+17,747
+30% +$1.19M 0.03% 283
2024
Q2
$6.94M Sell
58,466
-23,669
-29% -$2.81M 0.04% 227
2024
Q1
$8.75M Buy
82,135
+847
+1% +$90.3K 0.05% 182
2023
Q4
$8.08M Buy
81,288
+76,651
+1,653% +$7.62M 0.05% 183
2023
Q3
$479K Buy
4,637
+55
+1% +$5.68K ﹤0.01% 681
2023
Q2
$557K Sell
4,582
-11,499
-72% -$1.4M ﹤0.01% 629
2023
Q1
$2.47M Buy
16,081
+13,222
+462% +$2.03M 0.02% 289
2022
Q4
$514K Sell
2,859
-450
-14% -$80.8K 0.01% 518
2022
Q3
$391K Sell
3,309
-1,114
-25% -$132K ﹤0.01% 553
2022
Q2
$631K Sell
4,423
-15
-0.3% -$2.14K 0.01% 414
2022
Q1
$764K Buy
4,438
+1,187
+37% +$204K 0.01% 413
2021
Q4
$825K Buy
3,251
+398
+14% +$101K 0.01% 409
2021
Q3
$1.1M Buy
2,853
+1,231
+76% +$474K 0.02% 344
2021
Q2
$381K Buy
+1,622
New +$381K 0.01% 538